Oncolytic virus injection brings T cells into glioblastoma and prolongs survival
A single injection of a genetically modified herpes simplex oncolytic virus triggered durable T cell infiltration into brain tumors and was linked to longer survival in a 41-patient phase 1 trial, researchers report in Cell.